Overexpressed fibroblast growth factor receptor 2 in the invasive front of colorectal cancer: A potential therapeutic target in colorectal cancer

Cancer Letters

Volumn 309, Issue 2, 2011, Pages 209-219

  Matsuda, Yoko ^a   Ishiwata, Toshiyuki ^a   Yamahatsu, Kazuya ^a   Kawahara, Kiyoko ^a   Hagio, Masahito ^a   Peng, Wei Xia ^a   Yamamoto, Tetsushi ^a   Nakazawa, Nando ^a   Seya, Tomoko ^a   Ohaki, Yoshiharu ^a   Naito, Zenya ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Colorectal cancer; Fibroblast growth factor receptor 2; Growth; The invasive front

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 2; SHORT HAIRPIN RNA;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CELL INVASION; CELL MIGRATION; COLORECTAL CANCER; CONTROLLED STUDY; DRUG TARGETING; FEMALE; FGFR2 GENE; GENE; GENE EXPRESSION; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR VOLUME;

AGED; ANIMALS; ANTIBODIES, MONOCLONAL; CELL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; EXTRACELLULAR MATRIX; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION;

EID: 79960845455     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2011.06.009     Document Type: Article

References (46)

1. Chau I., Cunningham D. Treatment in advanced colorectal cancer: what, when and how?. Br. J. Cancer 2009, 100:1704-1719.
2. Tahara E. Growth factors and oncogenes in human gastrointestinal carcinomas. J. Cancer Res. Clin. Oncol. 1990, 116:121-131.
3. Ochs A.M., Wong L., Kakani V., Neerukonda S., Gorske J., Rao A., Riggs M., Ward H., Keville L. Expression of vascular endothelial growth factor and HER2/neu in stage II colon cancer and correlation with survival. Clin. Colorectal Cancer 2004, 4:262-267.
4. Narita K., Fujii T., Ishiwata T., Yamamoto T., Kawamoto Y., Kawahara K., Nakazawa N., Naito Z. Keratinocyte growth factor induces vascular endothelial growth factor-A expression in colorectal cancer cells. Int. J. Oncol. 2009, 34:355-360.
5. Sato T., Oshima T., Yoshihara K., Yamamoto N., Yamada R., Nagano Y., Fujii S., Kunisaki C., Shiozawa M., Akaike M., Rino Y., Tanaka K., Masuda M., Imada T. Overexpression of the fibroblast growth factor receptor-1 gene correlates with liver metastasis in colorectal cancer. Oncol. Rep. 2009, 21:211-216.
6. Yoshino M., Ishiwata T., Watanabe M., Komine O., Shibuya T., Tokunaga A., Naito Z. Keratinocyte growth factor receptor expression in normal colorectal epithelial cells and differentiated type of colorectal cancer. Oncol. Rep. 2005, 13:247-252.
7. Itoh N. The Fgf families in humans, mice, and zebrafish: their evolutional processes and roles in development, metabolism, and disease. Biol. Pharm. Bull. 2007, 30:1819-1825.
8. Itoh N., Ornitz D.M. Evolution of the Fgf and Fgfr gene families. Trends Genet. 2004, 20:563-569.
9. Katoh M. FGF signaling network in the gastrointestinal tract (review). Int. J. Oncol. 2006, 29:163-168.
10. Ibrahimi O.A., Eliseenkova A.V., Plotnikov A.N., Yu K., Ornitz D.M., Mohammadi M. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc. Natl. Acad. Sci. USA 2001, 98:7182-7187.
11. Mohammadi M., Olsen S.K., Ibrahimi O.A. Structural basis for fibroblast growth factor receptor activation. Cytokine Growth Factor Rev. 2005, 16:107-137.
12. Eswarakumar V.P., Lax I., Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005, 16:139-149.
13. Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D., Thompson D., Ballinger D.G., Struewing J.P., Morrison J., Field H., Luben R., Wareham N., Ahmed S., Healey C.S., Bowman R., Meyer K.B., Haiman C.A., Kolonel L.K., Henderson B.E., Le Marchand L., Brennan P., Sangrajrang S., Gaborieau V., Odefrey F., Shen C.Y., Wu P.E., Wang H.C., Eccles D., Evans D.G., Peto J., Fletcher O., Johnson N., Seal S., Stratton M.R., Rahman N., Chenevix-Trench G., Bojesen S.E., Nordestgaard B.G., Axelsson C.K., Garcia-Closas M., Brinton L., Chanock S., Lissowska J., Peplonska B., Nevanlinna H., Fagerholm R., Eerola H., Kang D., Yoo K.Y., Noh D.Y., Ahn S.H., Hunter D.J., Hankinson S.E., Cox D.G., Hall P., Wedren S., Liu J., Low Y.L., Bogdanova N., Schurmann P., Dork T., Tollenaar R.A., Jacobi C.E., Devilee P., Klijn J.G., Sigurdson A.J., Doody M.M., Alexander B.H., Zhang J., Cox A., Brock I.W., MacPherson G., Reed M.W., Couch F.J., Goode E.L., Olson J.E., Meijers-Heijboer H., van den Ouweland A., Uitterlinden A., Rivadeneira F., Milne R.L., Ribas G., Gonzalez-Neira A., Benitez J., Hopper J.L., McCredie M., Southey M., Giles G.G., Schroen C., Justenhoven C., Brauch H., Hamann U., Ko Y.D., Spurdle A.B., Beesley J., Chen X., Mannermaa A., Kosma V.M., Kataja V., Hartikainen J., Day N.E., Cox D.R., Ponder B.A. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447:1087-1093.
14. Hunter D.J., Kraft P., Jacobs K.B., Cox D.G., Yeager M., Hankinson S.E., Wacholder S., Wang Z., Welch R., Hutchinson A., Wang J., Yu K., Chatterjee N., Orr N., Willett W.C., Colditz G.A., Ziegler R.G., Berg C.D., Buys S.S., McCarty C.A., Feigelson H.S., Calle E.E., Thun M.J., Hayes R.B., Tucker M., Gerhard D.S., Fraumeni J.F., Hoover R.N., Thomas G., Chanock S.J. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 2007, 39:870-874.
15. Jang J.H., Shin K.H., Park J.G. Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. Cancer Res. 2001, 61:3541-3543.
16. Davies H., Hunter C., Smith R., Stephens P., Greenman C., Bignell G., Teague J., Butler A., Edkins S., Stevens C., Parker A., O'Meara S., Avis T., Barthorpe S., Brackenbury L., Buck G., Clements J., Cole J., Dicks E., Edwards K., Forbes S., Gorton M., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jones D., Kosmidou V., Laman R., Lugg R., Menzies A., Perry J., Petty R., Raine K., Shepherd R., Small A., Solomon H., Stephens Y., Tofts C., Varian J., Webb A., West S., Widaa S., Yates A., Brasseur F., Cooper C.S., Flanagan A.M., Green A., Knowles M., Leung S.Y., Looijenga L.H., Malkowicz B., Pierotti M.A., Teh B.T., Yuen S.T., Lakhani S.R., Easton D.F., Weber B.L., Goldstraw P., Nicholson A.G., Wooster R., Stratton M.R., Futreal P.A. Somatic mutations of the protein kinase gene family in human lung cancer. Cancer Res. 2005, 65:7591-7595.
17. Pollock P.M., Gartside M.G., Dejeza L.C., Powell M.A., Mallon M.A., Davies H., Mohammadi M., Futreal P.A., Stratton M.R., Trent J.M., Goodfellow P.J. Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene 2007, 26:7158-7162.
18. Adnane J., Gaudray P., Dionne C.A., Crumley G., Jaye M., Schlessinger J., Jeanteur P., Birnbaum D., Theillet C. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Oncogene 1991, 6:659-663.
19. Katoh M. Cancer genomics and genetics of FGFR2 (Review). Int. J. Oncol. 2008, 33:233-237.
20. Byron S.A., Gartside M.G., Wellens C.L., Mallon M.A., Keenan J.B., Powell M.A., Goodfellow P.J., Pollock P.M. Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation. Cancer Res. 2008, 68:6902-6907.
21. Gartside M.G., Chen H., Ibrahimi O.A., Byron S.A., Curtis A.V., Wellens C.L., Bengston A., Yudt L.M., Eliseenkova A.V., Ma J., Curtin J.A., Hyder P., Harper U.L., Riedesel E., Mann G.J., Trent J.M., Bastian B.C., Meltzer P.S., Mohammadi M., Pollock P.M. Loss-of-function fibroblast growth factor receptor-2 mutations in melanoma. Mol. Cancer Res. 2009, 7:41-54.
22. Byron S.A., Pollock P.M. FGFR2 as a molecular target in endometrial cancer. Future Oncol. 2009, 5:27-32.
23. Matsuike A., Ishiwata T., Watanabe M., Asano G. Expression of fibroblast growth factor (FGF)-10 in human colorectal adenocarcinoma cells. J. Nippon Med. School 2001, 68:397-404.
24. Kudo M., Ishiwata T., Nakazawa N., Kawahara K., Fujii T., Teduka K., Naito Z. Keratinocyte growth factor-transfection-stimulated adhesion of colorectal cancer cells to extracellular matrices. Exp. Mol. Pathol. 2007, 83:443-452.
25. Watanabe M., Ishiwata T., Nishigai K., Moriyama Y., Asano G. Overexpression of keratinocyte growth factor in cancer cells and enterochromaffin cells in human colorectal cancer. Pathol. Int. 2000, 50:363-372.
26. Pathology and Genetics of Tumours of the Digestive System 2000, IARC Press, Lyon. S.R. Hamilton, L.A. Aaltonen (Eds.).
27. Matsuda Y., Yamamoto T., Kudo M., Kawahara K., Kawamoto M., Nakajima Y., Koizumi K., Nakazawa N., Ishiwata T., Naito Z. Expression and roles of lumican in lung adenocarcinoma and squamous cell carcinoma. Int. J. Oncol. 2008, 33:1177-1185.
28. Cho K., Ishiwata T., Uchida E., Nakazawa N., Korc M., Naito Z., Tajiri T. Enhanced expression of keratinocyte growth factor and its receptor correlates with venous invasion in pancreatic cancer. Am. J. Pathol. 2007, 170:1964-1974.
29. Yamada K.M., Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007, 130:601-610.
30. Matsuda Y., Ishiwata T., Kawamoto Y., Kawahara K., Peng W., Yamamoto T., Naito Z. Morphological and cytoskeletal changes of pancreatic cancer cells in three-dimensional spheroidal culture. Mol. Med. Morphol. 2010, 43:211-217.
31. Vuillermoz B., Khoruzhenko A., D'Onofrio M.F., Ramont L., Venteo L., Perreau C., Antonicelli F., Maquart F.X., Wegrowski Y. The small leucine-rich proteoglycan lumican inhibits melanoma progression. Exp. Cell Res. 2004, 296:294-306.
32. Behrens C., Lin H.Y., Lee J.J., Raso M.G., Hong W.K., Wistuba, Lotan R. Immunohistochemical expression of basic fibroblast growth factor and fibroblast growth factor receptors 1 and 2 in the pathogenesis of lung cancer. Clin. Cancer Res. 2008, 14:6014-6022.
33. Nomura S., Yoshitomi H., Takano S., Shida T., Kobayashi S., Ohtsuka M., Kimura F., Shimizu H., Yoshidome H., Kato A., Miyazaki M. FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer. Br. J. Cancer 2008, 99:305-313.
34. Bane A.L., Pinnaduwage D., Colby S., Bull S.B., O'Malley F.P., Andrulis I.L. Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-associated tumors. Breast Cancer Res. Treat. 2009, 117:183-191.
35. el-Hariry I., Pignatelli M., Lemoine N. Fibroblast growth factor 1 and fibroblast growth factor 2 immunoreactivity in gastrointestinal tumours. J. Pathol. 1997, 181:39-45.
36. Zang X.P., Lerner M., Brackett D., Pento J.T. Influence of KGF on the progression of pancreatic cancer. Anticancer Res. 2009, 29:3417-3420.
37. Nguyen T.N., Zang X.P., Pento J.T. Keratinocyte growth factor stimulates the migration and proliferation of breast cancer cells in a culture wounding model. Pharmacol. Res. 2002, 46:179-183.
38. Zang X.P., Pento J.T. Keratinocyte growth factor-induced motility of breast cancer cells. Clin. Exp. Metastasis 2000, 18:573-580.
39. Shin E.Y., Lee B.H., Yang J.H., Shin K.S., Lee G.K., Yun H.Y., Song Y.J., Park S.C., Kim E.G. Up-regulation and co-expression of fibroblast growth factor receptors in human gastric cancer. J. Cancer Res. Clin. Oncol. 2000, 126:519-528.
40. Kurban G., Ishiwata T., Kudo M., Yokoyama M., Sugisaki Y., Naito Z. Expression of keratinocyte growth factor receptor (KGFR/FGFR2 IIIb) in human uterine cervical cancer. Oncol. Rep. 2004, 11:987-991.
41. Kawase R., Ishiwata T., Matsuda Y., Onda M., Kudo M., Takeshita T., Naito Z. Expression of fibroblast growth factor receptor 2 IIIc in human uterine cervical intraepithelial neoplasia and cervical cancer. Int. J. Oncol. 2010, 36:331-340.
42. R. Kawase, T. Ishiwata, Y. Matsuda, M. Onda, M. Kudo, T. Takeshita, Z. Naito, Expression of fibroblast growth factor receptor 2 IIIc in human uterine cervical intraepithelial neoplasia and cervical cancer, Int. J. Oncol. 36 331-340.
43. Chaffer C.L., Dopheide B., Savagner P., Thompson E.W., Williams E.D. Aberrant fibroblast growth factor receptor signaling in bladder and other cancers. Differentiation 2007, 75:831-842.
44. Carstens R.P., Eaton J.V., Krigman H.R., Walther P.J., Garcia-Blanco M.A. Alternative splicing of fibroblast growth factor receptor 2 (FGF-R2) in human prostate cancer. Oncogene 1997, 15:3059-3065.
45. Chaffer C.L., Brennan J.P., Slavin J.L., Blick T., Thompson E.W., Williams E.D. Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer Res. 2006, 66:11271-11278.
46. Oltean S., Sorg B.S., Albrecht T., Bonano V.I., Brazas R.M., Dewhirst M.W., Garcia-Blanco M.A. Alternative inclusion of fibroblast growth factor receptor 2 exon IIIc in Dunning prostate tumors reveals unexpected epithelial mesenchymal plasticity. Proc. Natl. Acad. Sci. USA 2006, 103:14116-14121.